Related Experiment Videos
[Cardiotoxicity of antineoplastic therapy]
1Oddĕlení funkcního vysetrování Fakultní nemocnice Brno, pracovistĕ Bohunice.
Vnitrni Lekarstvi
|October 26, 2000
Summary
Cardiotoxicity is a serious side effect of cancer treatments like chemotherapy. Anthracyclines can cause chronic heart failure, highlighting the need for monitoring and prevention strategies.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Context:
- Cardiotoxicity is a significant complication of anti-tumorous therapies.
- Cytostatics can induce various adverse cardiac events, including arrhythmias and heart failure.
- Chronic cardiac failure following anthracycline treatment is a major concern.
Purpose:
- To review frequent cardiac complications associated with anti-tumorous treatments.
- To highlight the cardiotoxicity of anthracyclines and discuss prevention.
- To underscore findings from recent studies on cardiac issues post-chemotherapy and transplantation.
Summary:
- This review examines common cardiac complications from anti-cancer treatments.
- It focuses on anthracycline cardiotoxicity, emphasizing its serious nature, particularly late-onset effects observed in pediatric studies.
- The authors discuss diagnosis, monitoring, and treatment of these cardiac issues.
Impact:
- Informs clinicians about potential cardiac risks of cancer therapies.
- Emphasizes the importance of early detection and management of cardiotoxicity.
- Provides insights into preventive measures for anthracycline-induced cardiac damage.